[Alpha-adrenoblocking activity of a newly synthesized derivative of 1,4-benzodioxane].
D000317:Adrenergic alpha-Antagonists / Q000138:chemical synthesis / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004146:Dioxanes / Q000138:chemical synthesis / Q000494:pharmacology* / Q000633:toxicity; D004147:Dioxins / Q000494:pharmacology*; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010880:Piperidines / Q000494:pharmacology*; D010883:Piperoxan / Q000031:analogs & derivatives / Q000138:chemical synthesis / Q000494:pharmacology* / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D014043:Tolazoline / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents; D004146:Dioxanes; D004147:Dioxins; D010880:Piperidines; D011942:Receptors, Adrenergic, alpha; C042726:MS 1-2; D010883:Piperoxan; D014043:Tolazoline; D009638:Norepinephrine
Vŭrkhu alfa-adrenoblokirashtata aktivnost na edno novosintezirano proizvodno na 1,4-benzodioksan.